A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine
The immune escape mutations of SARS-CoV-2 variants emerged frequently, posing a new challenge to weaken the protective efficacy of current vaccines. Thus, the development of novel SARS-CoV-2 vaccines is of great significance for future epidemic prevention and control. We herein reported constructing...
Saved in:
Main Authors: | Ziyu Wen (Author), Cuiting Fang (Author), Xinglai Liu (Author), Yan Liu (Author), Minchao Li (Author), Yue Yuan (Author), Zirong Han (Author), Congcong Wang (Author), Tianyu Zhang (Author), Caijun Sun (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of the biochemistry of Mycobacterium smegmatis, as a possible model for Mycobacterium tuberculosis
by: Joseph Antony Sundarsingh T, et al.
Published: (2020) -
Antimycobacterial activity of fruit of Zanthoxylum acanthopodium DC against Mycobacterium smegmatis
by: Heddy Julistiono, et al.
Published: (2018) -
Identification of Mutations Conferring Tryptanthrin Resistance to <i>Mycobacterium smegmatis</i>
by: Svetlana G. Frolova, et al.
Published: (2020) -
Inhibition of biofilm formation in Mycobacterium smegmatis by Parinari curatellifolia leaf extracts
by: Benjamin Bhunu, et al.
Published: (2017) -
Development of Recombinant Antibody by Yeast Surface Display Technology
by: Mujahed I. Mustafa, et al.
Published: (2024)